Correlation Between Rekah Pharmaceutical and Nextage Therapeutics

Can any of the company-specific risk be diversified away by investing in both Rekah Pharmaceutical and Nextage Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rekah Pharmaceutical and Nextage Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rekah Pharmaceutical Industry and Nextage Therapeutics, you can compare the effects of market volatilities on Rekah Pharmaceutical and Nextage Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rekah Pharmaceutical with a short position of Nextage Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rekah Pharmaceutical and Nextage Therapeutics.

Diversification Opportunities for Rekah Pharmaceutical and Nextage Therapeutics

0.33

Correlation Coefficient

Rekah Pharmaceutical  Nextage Therapeutics

Weak diversification

The 3 months correlation between Rekah and Nextage is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Rekah Pharmaceutical Industry and Nextage Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextage Therapeutics and Rekah Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rekah Pharmaceutical Industry are associated (or correlated) with Nextage Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextage Therapeutics has no effect on the direction of Rekah Pharmaceutical i.e., Rekah Pharmaceutical and Nextage Therapeutics go up and down completely randomly.

Pair Corralation between Rekah Pharmaceutical and Nextage Therapeutics

Assuming the 90 days trading horizon Rekah Pharmaceutical Industry is expected to under-perform the Nextage Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Rekah Pharmaceutical Industry is 2.43 times less risky than Nextage Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Nextage Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  8,530  in Nextage Therapeutics on December 30, 2024 and sell it today you would earn a total of  930.00  from holding Nextage Therapeutics or generate 10.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Rekah Pharmaceutical Industry  vs.  Nextage Therapeutics

Rekah Pharmaceutical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Rekah Pharmaceutical Industry has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Rekah Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Nextage Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Nextage Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nextage Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Rekah Pharmaceutical and Nextage Therapeutics

The main advantage of trading using opposite Rekah Pharmaceutical and Nextage Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rekah Pharmaceutical position performs unexpectedly, Nextage Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextage Therapeutics will offset losses from the drop in Nextage Therapeutics' long position.

The idea behind Rekah Pharmaceutical Industry and Nextage Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.